Viewing Study NCT06387056


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-11 @ 2:38 AM
Study NCT ID: NCT06387056
Status: RECRUITING
Last Update Posted: 2024-04-26
First Post: 2024-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Sponsor: The First Affiliated Hospital of Xiamen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Prostate Cancer View
None Oligometastatic Prostate Cancer View
Keywords: